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Dendritic cells are potent antigen-presenting cells for severalprimary immune responses and therefore
provide an opportunity for evaluating the amounts of cell-associated antigens that are required
for inducing T cell-mediated immunity. Because dendritic calls express very high levels of major
histocompatibility complex (MHC) class II products, it has been assumed that high levels of
ligands bound to MHC products ("signal one") are needed to stimulate quiescent T cells. Here
we describe quantitative aspects underlying the stimulation of human blood T cells by a bacterial
superantigen, staphylococcal enterotoxin A (SEA). The advantages of superantigens for quantitative
studies of signal one are that these ligands: (a) engage MHC class II and the T cell receptor
but do not require processing; (b) are efficiently presented to large numbers of quiescent T cells;
and (c) can be pulsed onto dendritic cells before their application to T cells. Thus one can relate
amounts of dendritic cell-associated SEA to subsequent lymphocyte stimulation. Using
radioiodinated SEA, we noted that dendritic cells can bind 30-200 times more superantigen than
B cells and monocytes. Nevertheless, this high SEA binding does not underlie the strong potency
of dendritic cells to present antigen to T cells. Dendritic cells can sensitize quiescent T cells,
isolated using monoclonals to appropriate CD45R epitopes, after a pulse of SEA that occupies
a maximum of 0.1% of surface MHC class II molecules. This corresponds to an average of 2,000
molecules per dendritic cell. At these low doses of bound SEA, monoclonal antibodies to CD3,
CD4, and CD28 almost completely block T cell proliferation. In addition to suggesting new
roles for MHC class II on dendritic ceils, especially the capture and retention of ligands at low
external concentrations, the data reveal that primary T calls can generate a response to exceptionally
low levels of signal one as long as these are ddivered on dendritic ceils.

uring the initiation of an immune response, the antigen
D
receptor-CD3 complex on T lymphocytes engages either peptide fragments or superantigens bound to MHC molecules on APCs, an event that is commonly referred to as
"signal one:' To date there is little quantitative information
on signal one using quiescent T cells. There are reports using
cell lines as APCs and/or T cells (1, 2) where it has been
found that only a few hundred MHC-peptide complexes are
needed to stimulate IL-2 release from T-T hybridomas, for
example. The affinity of these T cell lines may not be representative of bulk T cells, however, and the signal one requirements may be lower than quiescent T cells. The use of APCs
and T cell lines may also obscure the contribution of accessory molecules that are thought to lead to the full complement of events that are needed during T cell growth and
differentiation. Superantigens provide a means to pursue quan633

titative aspects of antigen presentation to human T cells. These
molecules, many of them staphylococcal enterotoxins (SEs)1,
resemble processed peptide antigens in the sense that they
engage both the MHC class II molecules and the TCK
(reviewed in reference 3). The experimental advantage of superantigens is that they do not require cellular processing (4,
5), so that one can better quantitate with trace-radiolabeled
materials the amount of ligand associated with the APCs.
Superantigen-pulsed APCs, particularly dendritic cells, stimulate responses in large numbers of quiescent T cells (6).
In this paper we use superantigens and dendritic cells in
combination to gain information on the levels of signal one
that are needed for primary T cell stimulation. Several ret Abbreviation used in this paper: SE, staphylococcal enterotoxin.
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Summary

Materiah and Methods

Culture Medium. R.PMI 1640 (Gibco Laboratories, Grand Isbud, NY), supplemented with 5% human serum, 50 gg/ml gentamycin, and 10 mM Hepes was used throughout these studies except where indicated. Human sera were obtained from normal
donors and were screened to ensure that they supported SEA-induced
T cell proliferation at femtomolar concentrations. Sera used were
similar to FCS in inducing responses to SEA (data not shown).
Commercial sources of pooled human sera, however, have been
problematic in supporting SEA-induced proliferation, presumably
because of the presence of antistaphylococcal antibodies, and were
not used here.
Prelmration of Lymphoid Cells. Burly coats were obtained from
the New York Blood Center and separated into T cell-enriched
(ElL +) and T cell-depleted (ElL-) fractions by rosetting with
neuraminidase-treated SRBC.
T Cells. ER + cells were depleted of non-T cell contaminants
first by panning on petri dishes coated with human gamma globulin
to remove FcR+ cells (12), and then coating MHC class II-positire cells with anti-DlL/DQ mAb 9.3C9 (IgG2a, subclone of
HB180; American Type Culture Collection, lLockville, MD) followed by panning on petri dishes coated with goat anti-mouse
IgG (55459; Cappel Laboratories, Organon Teknika, Durham, NC
[13, 14]). In some experiments T lymphocytes were prepared by
passage of nonadherent ElL + cells over nylon wool columns before panning with anti-MHC class II antibodies. The resulting T
cell preparations failed to proliferate to optimal doses of superantigens, indicating negligible contamination with APCs.
CD4 + T Cells. These were enriched by negative selection of
bulk T cells. The latter were incubated with o~CD8 (OKT8, IgG2a,
ATCC CRL 8014) and c~2Dllb (OKM1, IgG2b, ATCC CRL 8026)
and panned on petri dishes coated with goat anti-mouse IgG.
Naive and memory CD4 + subsets were negatively selected in a
similar fashion by panning CD4 + T cells coated with c,CD45RO
(UCHL-1, IgG2a; gift of Dr. P.C.L. Beverley, Imperial Cancer Research Technology, London, UK) or ~CD45RA (4G10, IgG2a),
respectively. CeUs depleted by panning constituted g2-3% of the
resulting subpopulation as monitored by cytofluorography. The enrichment of CD4 + naive and memory T cell subsets was moni634

tored by their relative responses to a crude extract of Candida albicans diluted 1:20 final in the presence of APCs.
APC Popu/at/0ns. To obtain monocytes, the ElL- or T-depleted
fraction was adhered to plastic for 60-90 min and subsequently
dislodged by pipetting. The nonadherent non-T cells were subsequently used for purification of B cells and dendritic cells, lLesidual
monocytes were first depleted from these populations by panning
on gamma globulin-coated plates (12) and then layered onto 13-14
g% metrizamide (15). After sedimentation at 650 g for 10 min,
B cells and a few NK cells localized to the high-density pellet while
dendritic cells were enriched in the low-density interface. The purity of dendritic cells ranged from 50 to 75% with contaminants
being primarily small B and NK cells.
Lyraphoblastoid Cell Lines. The Cox (MHC class II +) and Ket
(BLS1, MHC class II-) cell lines were gifts of Dr. P. Cameron and
Dr. J. S. Lee (16), respectively. They were maintained in 1LPMI
supplemented with 10% FCS. We confirmed that the Ket cell lines
lacked surface expression of class II molecules by staining with antiMHC class II antibodies.
Mitogens. Highly purified SEA was purchased from Toxin Technology (Sarasota, FL). The mitogen was aliquoted to 1 mg/ml in
sterile water, filtered, and stored at -20~ until use. SEA was
confirmed to be >95% pure by SDS-PAGE and Coomassie staining.
Iodination of SEA. SEA was iodinated using lactoperoxidase/glurose oxidase (Enzymobead Radioiodination Reagent; Bio-Rad Labs,
Richmond, CA [17]), and specific activities ranged from 1.3 to 3.4
x 107 cpm//~g. The eflidency of iodination was 0.14 _+ 0.04 tool
of mI/mol of SEA (n = 6 experiments). SEA was confirmed to
be >95% pure by SDS-PAGE and autoradiography after iodination. Labeled and unlabeled SEA preparations were equally effective in stimulating T cells (not shown).
SEA Binding Assay. Aliquots of 10s to 2 x 106 of each APC
type were incubated in 0.2 ml RPMI 1640/5% human serum and
concentrations of 12sI-SEA ranging from 0.015 to 150 nM for
1-1.5 h at 4oC or 37~ in plastic microfuge tubes over a mixture
of phthalate oils. At the termination of the assay, the tubes were
spun at 8,000 g for 2 rain, the tips containing cell pallets were
cut off, and this portion ("bound") plus the cell-free component
("free") were counted in a gamma counter (18). Nonspecific binding
was determined from parallel tubes containing a 300-fold excess
of unlabeled toxin.
Lymphocyte Proliferation Assays. APCs were added directly to
cultures of T cells in the continuous presence of SEA (nonpulsed
APCs) or were first pulsed with SEA as described below (pulsed
APCs).
Nonpulsed APCs. Graded doses of viable APCs were added to
10s purified T cells in 96-well flat-bottomed plates (Costar, Cambridge, MA) in the continuous presence of nSI-labeled or nonlabeled SEA. The APC/T ratio ranged from 1:30 to 1:1,000. The
Cox and Ket lines were 3,-irradiated (7,000 rad, 137Cs) to prevent
multiplication in culture. The contribution of an allogeneic MLR
(responders and stimulators in the absence of superantigen) was
minimal at the doses of APCs used and at the time points we assayed the cultures. Here, the mean [3H]TdlL uptake was <3,500
and <2,000 cpm for Cox and Ket cells, respectively. Dendritic cells,
monocytes, and B cells were always syngeneic to the T cells and
functioned similarly with or without prior irradiation. Proliferation was determined on day 3 with the addition of 1 #Ci [3H]thymidine for 12 h to triplicate microwells (mean cpm).
PulsedAPCs. For pulsing studies, APCs were incubated at 2 x
l& cells/ml for 1-1.5 h at 4~ or 37~ with 0.005-50 nM of
radioiodinated or nonlabeled SEA, washed extensively, and added
back to T cells as above.

Dendritic Calls Present Low Levels of Signal One
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sponses are initiated by antigen-bearing dendritic cells, including the induction of helper T cells for protein antigens
(7, 8) and transplant rejection in situ (9, 10). Dendritic cells
express very high levels of M H C class II, so that it has been
tacitly assumed that the efficacy of these APCs relates to the
higher amounts of MHC-peptide complexes that can be
presented. Alternatively, function may be attributed to the
presence on dendritic cells of several accessory molecules for
T cell signaling (11). These hypotheses have been difficult
to pursue directly, since it has not been possible to measure
the levels of conventional antigenic peptides that are presented
on M H C products by dendritic cells. Here we use radioiodinated SEA and human blood dendritic cells to gain such quantitative information. While blood dendritic cells, not surprisingly, bind much higher levels of SEA than other APCs,
we find that very small numbers of superantigen-MHC class
II complexes are sufficient to trigger resting primary T cells.
At these low doses, triggering entails a major role of both
CD4 and CD28 accessory molectdes.

l~esuks
SEA Binds in Large Amounts to M H C Class II Molecules
on Dendritic Cells and with High Affinity. M H C class II molecules represent the major binding sites for superantigen on
APCs (19-24). The number of class II binding sites on dendritic ceils has not been evaluated in a quantitative manner
with iodinated superantigens. We performed binding studies
comparing dendritic cells to other primary populations of
APCs such as B cells and monocytes. To quantify the amount
of superantigen that can be bound, enriched populations of
different APCs were exposed to iodinated SEA for 1-1.5 h
at 4~ vs. 37~ SEA was chosen since highly purified and
stable preparations are available. Prior studies with toxic shock
syndrome toxin 1 (TSST-1) and SEB have shown that equilibrium binding is usually complete within 1 h (22, 23).
Binding of SEA to dendritic cells was compared first to the
class II-positive and -negative B cell lines Cox and Ket/BLS1
(the latter obtained from a patient with bare lymphocyte syndrome [16]). The binding characteristics of iodinated SEA
to Cox, the class II-positive B cell line, and dendritic cells
were similar. Saturable binding was evident (Fig. 1 A); and
by Scatchard analysis, the data were consistent with a single
receptor, most likely class II (Fig. 1 B). SEA bound to dendritic cells and Cox ceils with high affinity (mean Ka's
ranging from 5.6 to 13.4 nM) and to similar numbers of MHC
class II molecules at saturation (average of 1.9-3.2 x
105/cdl; Table 1). It has previously been demonstrated that
TSST-1 and SEB show saturable binding to APCs with Ka's
in the range of 17-43 nM (19, 22) and 1/zM (20), respectively. SEA reportedly shows ,,o10-30-fold higher affinity for
M H C class II molecules than SEB on B cell lines (21). For
M H C class II-transfected L cells, Kd's for SEA range from
82 to 143 nM (25). D R alleles have been shown to differ
in their ability to bind SEA (26). Since our dendritic cells
were obtained from burly coat preparations, it was not possible to correlate the Ka's measured to the D R phenotype.
It is likely that a broad range of D R phenotypes was studied,
as reflected by the range of Ka's obtained (Table 1). Substantial differences in on-rates for SEA at 4~ vs. 37~ have been
described (21). Although large differences in Ka's at these
635
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Table 1. Cellular Distribution of SEA Binding Sites
Call type
(no. of exps.)

Mean no. of sites
per cell
(range)

Cox
(n = 5)
Dendritic cells
(n = 7)
B cells
(n = 4)
Monocytes
(n = 2)

3.2 x 10~
(0.2 x 106-6 x 10~)
1.9 x 10s
(0.2 x 106-3.6 x 10~)
6.4 x 104
(2.3 x 104-1.2 x 10s)
9.3 x 103
(4.5 x 103-1.4 x 104)

Mean Ka -+ SD
M

x

1 0 -9

13.4 _+ 9.3
5.6 _+ 4.5
1.5 _+ 0.4
1.7 _+ 1.2

Ka values and number of SEA binding sites per cell were calculated as
describedin Fig. 1. For Cox cells and dendritic cells, 105 cellswere used
per binding assay,while higher numbers (2 x 106)were used for monocytes and B cells. The number of SEA binding sites on dendritic cells
may be an underestimate, since the purity of our preparations ranged
from 50 to 75% (Fig. 1).
two temperatures were not detected here, we did not directly
measure the on-rate as a function of time.
When dendritic cells or Cox cells were treated with an
anti-class II antibody (L243 or 9.3C9), before and during the
SEA binding assay, at least 50% of the specific binding was
inhibited (data not shown), similar to findings with TSST-1
on tonsillar B cells (19). Control anti-CD14 antibody had
no effect on binding of SEA to Cox cells (data not shown).
Interestingly, the class II-negative Ket/BLS1 cell line obtained from a patient with bare lymphocyte syndrome (16)
showed specific binding of lzsI-SEA, but this only became
detectable at a relatively high concentration, 15 riM, and saturation could not be achieved (Fig. 1, A and B). An accurate
estimate of these apparently low affinity superantigen-binding
sites on the Ket cell line could not be determined, even when
the numbers were increased 10-fold. Thus, besides binding
to MHC dass II-dependent, saturable high affinity sites, SEA
also uses an M H C class II-independent pathway to interact
with T cells, as previously suggested for SEB (27).
Dendritic cells were then compared with other primary
APCs from blood, i.e., B cells and monocytes. These APCs
are known to express lower levels of M H C class II products
than dendritic cells using cytofluorographic assays (6, 15, 28).
When low numbers of cells were used (105/assay), as is required for dendritic cells, which are a trace cell population
in blood, saturable binding could only be achieved with dendritic and B cells (Fig. 1 C). The B cells bound an average
of 64,000 SEA molecules (range of 2.3 x 104 to 1.2 x 105),
i.e., 30 times less than dendritic cells. To compare dendritic
cells with monocytes more effectively, it was necessary to increase the number of monocytes per binding assay to 2 x
106. Monocytes bound only 4,500-14,000 molecules/cell
(Table 1), much less than the level of binding to dendritic
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Anti-MHC ClassII mAbs. Anti-MHC class II antibodies were
used to block APC presentation of SEA to T cells. They consisted
ofL243 (anti-DR, IgG2a, ATCC I-IB55)and 9.3F10/subclone9.3C9
(anti-DK/DQ, IgG2a, ATCC HB 180), Matched isotype controls
were used at identical concentrations.
Assays to Evaluate the Contributionof CostimulatorMolecules in Superantigen Presentation. 10s T cells per flat-bottomed microwell
were incubated at 4~ for 30 min with purified mAbs of the following specificities: otCD3 and etCD4 (Leu-4 and Leu-3a hybridomas, respectively, both IgG1; gifts of Dr. R. Evans, New York,
NY); c~I-ILADR/DQ (9.3Pl0/subclone 9.3C9, IgG2a, ATCC HB
180); and otCD28 (9.3, IgG2a; gift of Dr. E.A. Clark, Seattle, WA).
Commercial murine IgG1 (MOPC 21) and IgG2a (UPC 10; Sigma
Chemical Co., St. Louis, MO), dialyzed free of azide, were used
as isotype controls. Syngeneic dendritic cells were prepared as outlined above and "pulsed" with SEA (0.005 nM) for 1 h at 37~
before mixing with T ceils at a responder/stimuhtor ratio of 100:1.
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cells, Scatchard plots calculated from several experiments
demonstrated that the affinity of binding to monocytes was
similar to that measured on dendritic cells and the Cox cell
line (Table 1), indicating that the receptor on these populations (presumably MHC class II) is identical.

Quantitation of Dendritic Cell MHC Class II-Superantigen
Complexes Necessaryfor T Cell Stimulation. The minimal
number of class II molecules that must be occupied by antigen on a dendritic cell for T cell activation is not known.
Studies with long-term APC and T cell lines suggest that
the amount of MHC-peptide complexes could be very small
(200-600/APC), and the extent of MHC occupancy likewise
~<0.1% (1, 2). It has been speculated that the large numbers
of class II molecules on dendritic cells (6, 15, 28) account
for their potency in several primary responses (29). To determine how many class II molecules must be occupied by superantigen to stimulate primary T cells, we pulsed dendritic
cells and other APCs with different doses of iodinated SEA.
We then quantified the number of receptors bound at each
dose, and added parallel aliquots of APCs in graded doses
to purified blood T cells to evaluate their functional potential in a proliferation assay. Dendritic cells and Cox cells were
equally stimulatory, whether pulsed with SEA or exposed
continuously to the superantigen during cocuhure with T
ceils (Fig. 2 A). Ket cells were only effective in stimulating
T cells when SEA was continuously present in the cultures,
consistent with our data that these APCs have low affinity
SEA binding sites (Fig. 1) and probably cannot capture SEA
weU in pulse protocols.
SEA-pulsed B ceils and monocytes were much less effident
stimulators of T cell proliferation than dendritic calls, even
at higher doses of SEA and substantially higher APC/T cell
ratios (Fig. 2 B). Dendritic ceils pulsed with 0.005 nM (5
pM) of SEA effectively stimulated T cells at ratios of
1:100-1,000, whereas monocytes or B cells pulsed with up
to 50 nM SEA induced lower responses even at APC/T cell
ratios of 1:30 (Fig. 2 B). Dendritic cells pulsed with 1,000fold less SEA (0.050 vs. 50 nM) bind similar levels of SEA
per cell, relative to B cells, but are effective at <1/30 the
636
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number of B cells required to generate an equivalent T call
response. For example, it was necessary to use 3.3 x 103 B
cells (APC/T, 1:30) pulsed with 50 nM SEA to attain a similar
degree of T cell stimulation as that obtained with 100 dendritic cells (APC/T, hl,000) pulsed with only 50 pM of superantigen.
B cells and monocytes did stimulate T cells more effectively if SEA were continuously present in culture and at relatively high doses. Interestingly, monocytes appeared to be
more efficient than B cells in this situation, even though the
former bind significantly less SEA (Fig. 1 C) and have fewer
MHC class II molecules on their surface (6, 15, 28). Our
studies deal with primary B cells in blood, but it is possible
that activated B cells would resemble B cell lines and stimulate superantigen responses better than resting blood B cells.
However, is is not yet evident that superantigen or antigen
will stimulate a sufficient number of B lymphocytes to permit
such a function for the activated B cell in vivo.
The dose-response curves that describe the binding of SEA
to dendritic cells, and the efficacyof superantigen-pulsed APCs
in stimulating T cells, are strikingly different (Fig. 3). At
stimulator-to-responder ratios of 1 dendritic cell to 100 T
cells, half-maximal proliferation was achieved after an SEA
pulse of only 50 pM, whereas half-maximal occupancy of
receptors occurred at 5 nM. Therefore one needs 100-fold
less superantigen to induce half-maximal proliferation of T
cells than to occupy half the available high affinity receptors.
At 50 pM SEA, the dose required for half-maximal stimulation, only 1% of receptors (presumably MHC class II) are
bound with superantigen. At 5 pM, where strong T cell responses are still evident, only 0.1% of receptors or •2,000
occupied MHC molecules are required (see Table 1).
FunctionalFeaturesof SEA Binding to DendriticCells. Since
dendritic ceils were active APCs when pulsed with low levels
of superantigen, a high aff~ty binding site, most likely MHC
dass II, seemed essential. Addition of anti-MHC dass II mAbs
to dendritic cell-T cell cultures in the presence of SEA virtually abrogated presenting ability to T ceUs (Fig. 4; note log
axis, block is >95%). Similar results were obtained with the

Dendritic Cells Present Low Levels of Signal One
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Figure 1. Concentration-dependent binding of lZSl-labeledSEA to
APCs. Dendritic cells, B cells, and
monocytes were enriched from
human buffy coat preparations as
previously described (15). The B cell
lines Cox and Ket/BLS1 were maintained in culture as described (see
Materials and Methods). (.4) SEA
binding activity of dendritic cells
(DC), Cox cells, and Ket cells; (B)
Scatchard plot analysis of the
binding data in A for Cox and K~t
cells; (C) SEA binding activity of
dendritic cells (DC), B cells (B), and
monocytes (Mck) obtained from the
same donor. Scatchard plot of the
dendritic cell data is shown in the
inset. All binding studies were performed at 4~
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Cox cell line, but not the MHC class II-negative Ket cell
line (data not shown), where the induction ofT cell proliferation was minimally affected by the addition of anti-MHC
class II antibodies.
We next determined if dendritic cells could retain immunogenic MHC-superantigen complexes for long periods. SEApulsed dendritic cells, in fact, retained detectable 12sI-SEA
(not shown) and could activate T cells if tested 48 h after
the pulse (Fig. 5).
Subsets of blood T cells can be distinguished on the basis
of isoforms of the leukocyte common antigen CD45. The
CD45RO + CD45RA- subset contains most antigenprimed or memory T cells, whereas CD45RO- CD45RA §
cells do not have reactivity to these recall antigens and are
considered to be naive (30, 31). Superantigens have been shown
to stimulate both populations (32), but the role of dendritic
637
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Figure 2. Presentation of SEA
by different APCs. (,4) SEA-pulsed
dendritic cells and Cox cells, but not
MHC class If-negative Ket cells,
ef~ciently induce T cell proliferation. Dendritic cells, Cox cells, and
Kct ceils were added to purified
blood T cells in the continuous presence of 12sI-SEA (nonpulsed
APCs), or were pulsed for 1 h at
4~ with 0.005-50 nM of IzsISEA, washed extensively, and added
back to T cells (pulsed APCs). The
APC/T ratio was 1:100. Proliferation was determined on day 3 with
the addition of I #Ci [3H]thymidine for 12 h to triplicate microwells
(mean cpm). (B) Dendritic cells are
more potent APCs than B ceils or
monocytes in stimulating T cell responses to SEA. Dendritic ceils
(DC), monocytes (MS), and B cells
derived from the same donor were
pulsed with SEA at37~ orthe
APCs were added directly to T cells
in the continuous presence of SEA
at various APC/T cell ratios
(1:30-1,000).

cells has not been evaluated. We separated blood T cells into
CD4 + naive and memory subsets and measured their responses to SEA presented by dendritic cells. Both the naive
and memory T cells responded to dendritic cells pulsed with
5 pM to 0.5 nM SEA (Fig. 6). The naive population was
more limited in its response at the lower doses of SEA, but
was equivalent to the other populations at higher doses in
several experiments. To monitor the cell populations, we
verified that the memory cells responded to the recall antigen
C. albicans while the naive cells were depleted of recall reactivity (Fig. 6, inset). These results confirm that quiescent or
resting T cells respond significantly to a small number of
superantigen-MHC dass II complexes on dendritic cells.
Contribution of Accessory or Costiraulator Molecules to the T
Cell Response. Dendritic ceUs are unusual among primary

leukocytes in their comparatively high expression of acces-
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percentILoccupancyis calculatedfrom the followingequation: 100x [ligand
concentration/(Ka + ligand concentration)], where Ka = 5 nM.
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Figure 5. Dendritic cells pulsed with SEA retain superantigen for at
least 2 d in culture. After pulsing with 0.5 nM SEA, dendritic calls were
left in culture for 0, 1, or 2 d and then added to purified T cells at various
APC/T cell ratios. Proliferation was determined on day 3 after an overnight pulse with 1 #Ci of [3H]TdR.

sory ligands for T cell stimulation: e.g., CD54 (ICAM-1),
CD58 (LFA-3), and B7/BB1 (11, 15), the respective APC
ligands for CDlla, CD2, and CD28 on T cells. It seemed
likely that these molecules might serve as accessories to allow
primary T cells to respond to such low doses of superantigen.
mAbs against these accessory molecules and their ligand pairs
can be effective blockers of T cell responses (11, 33). In addition, some of these molecular pairs have been shown to deliver costimulatory signals together with superantigen (34--37).
CD28 signal transduction appears to provide a critical costimulatory mechanism for IL-2 gene activation (35, 38, 39).
We therefore assessed T cell responses to dendritic cells
pulsed with low doses of SEA in the presence of varying concentrations of mAb to CD28 (9.3). The inhibition achieved
by blocking the CD28 costimulatory pathway with an antiCD28 mAb was in the 80-90% range compared with its
isotype-matched control (Fig. 7). This degree of inhibition
was almost as great as that achieved by interfering with the
a n t i g e n / M H C - C D 3 / T C R complex, using mAbs to either
CD3 or M H C class II, or to the CD4 antigen.
Discussion

Dendritic cells represent a widely distributed system of
APCs that is particularly active for the induction of T
ceU-mediated immunity (reviewed in reference 29). Among
the many stimuli that are effectively delivered are several
microbial superantigens (6). By isolating dendritic cells from
human blood, and by using superantigens as the ligand to
be presented to T cells, several quantitative features of APC
function have become apparent and are discussed individually here. Essential to the analysis is the fact that superan-
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Figure 6. Dendritic cells pulsed with SEA stimulate both naive and
memory T cells. Bulk T lymphocytes (O), CD4 + T cells (El), and naive
(A) and memory ( ~ ) CD4 + subsets were prepared as described in
Materials and Methods. 10s T cells per flat-bottomed microwell were
stimulated by syngendc dendritic cells (T/DC, 150:1) that had been pulsed
with 0.005, 0.05, or 0.5 nM SEA for 1 h at 370C before mixing with
T cells. All cultures were pulsed with I/~Ci pH]TdR, from 56 to 66 h.
Proliferation was calculated from triplicate microwells (mean cpm). (Inset)
Monitoring the enrichment of CD4 + T cell subsets. T cells from the same
experiment outlined above were also cocuhured with syngeneic dendritic
cells (30:1) and a crude extract ofC. albicansdiluted 1:20 final. All cultures
were pulsed with 1/~Ci [3H]TdR from 64 to 76 h (C albicans). Proliferation was calculated from triplicate microweils (mean cpm). Data are representative of four experiments.

tigens do not appear to undergo processing but instead directly
engage M H C class II molecules on the APC and subsequently
bind to V/3 segments of the T C R (4, 5, 21, 40). This enables
one to pulse APCs with sutxa'antigen, and then relate amounts
of APC-associated superantigen to subsequent lymphocyte
stimulation. This method has provided quantitative information on signal one for the first time using quiescent T
cells and APCs from humans. In addition, we have been able
to compare superantigen binding and presentation by APCs
quantitatively and to evaluate the contribution of costimulator molecule pairs (signal two) when known amounts of
ligand are bound to the APC.
Pulse, rather than continuous, exposure to superantigen
is critical for the analysis presented here, since it permits direct measurement of the maximal amount of superantigen
that is conveyed by APCs during T cell stimulation. Mollick
et al. (25) estimated that small amounts of bound SEA were
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Figure 7. Contribution of costimuhtor molecules to dendritic celldependent superantigen-induced proliferation of T cells. 10s bulk T lymphocytes (O) and CD4 + T ceils ([]) per flat-bottomed microwell were
incubated at 4*C for 30 min with purified mAbs of the following
specifidties: o~CD3, c~CD4, ~HLA DR/DQ, and c~CD28 (--) or isotype
controls ( - - - -). Syngeneic dendritic cells were pulsed with 0.005 nM
SEA for 1 h at 370C before mixing with T cells at a responder/stimulator
ratio of 100:1. The final mAb concentrations are indicated along the abscissae. Cultures were pulsed with 1/zCi [3H]TdR from 60 to 70 h.
Proliferation was determined from triplicate microwells (mean cpm) for
each condition. Additional controls for [3H]TdR.incorporation (cpm x
10-3 _+ SD) included T cells + SEA-pulseddendritic cells in the absence
of mAb: bulk, 17.658 _+ 4.764; CD4 +, 15.869 +_ 0.290. T calls only:
bulk, 0.105 _+ 0.018; CD4 +, 0.104 + 0.004. SEA-pulsed dendritic cells
only: 0.051 _+ 0.027. Data are representative of four experiments.

sufficient for T cell stimulation by L cells transfected with
M H C dass II molecules. However, the SEA was applied continuously rather than in a pulse. During continuous exposure,
APCs could accumulate significant amounts of SEA after
binding, and reservoirs of low affinity binding sites could contribute additional SEA.
Dendritic cells bind much larger amounts of superantigen
than do other APCs like monocytes and B cells (Fig. 1 C
and Table 1). This might have been predicted from the higher
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bution to T cell stimulation by low levels of MHC-superantigen complexes. The inhibition that was observed was greater
than that documented previously in the primary MLR (11).
Unfortunately it is not possible to quantitate the levels of
MHC-peptide complex that are being presented to T cells
in the MLK. CD28-B7-independent stimulation of T cells
with superantigen has been described (37). However, in these
studies, tither high doses of SEA, added on a continuous basis,
or APCs (B cell line) were used. Under these conditions, the
amount of SEA that binds directly to APCs cannot be
quantified. It is possible that higher amounts of ligand may
be less dependent on accessory molecules, as postulated for
the CD2-CD58 (43) and CDlla-CD54 interactions (44).
These data provide insight on the exceptional qualities of
the dendritic cell in eliciting primary responses. First, dendritic ceils can present low amounts of the MHC class II-SEA
complex (signal one) and several costimulatory molecules or
signal two (ICAM-1, LFA-3, BT/BB1 [11]) simultaneously
to T cells to which dendritic cells bind efficiently and for
days (13). Second, the high number of dass II molecules (~2
x 106) on its surface would permit the dendritic cell to bind
several hundred peptides simultaneously, at concentrations
that would be functionally active. For example, 1,000 peptides, each occupying 2,000 class II molecules, could be accommodated. Thus, even if a diversity of peptides are generated from complex antigens, assuming that they can be bound
by class II molecules, many could be presented by the dendritic cell at one time.
If large amounts of signal one are not required for dendritic cells to initiate a primary T cell response, what might
be the function of large amounts of MHC class II on dendritic cells? One function would be to allow dendritic cells
to capture ligand (superantigens and peptides) at very low
external concentrations. A second is that high levels of superantigen might lead to better retention of antigen in the
long term especially in situ. Superantigens and possibly other
ligands dissociate from MHC molecules at a finite rate (22).
Dendritic cells pulsed with 0.5 nM SEA are stimulatory for
T cells that are added as much as 2 d later (Fig. 5). These
possibilities are relevant in vivo, where dendritic cells capture antigens more efficiently than other APCs (45) and can
migrate to the T cell areas of lymphoid tissues (46) and prime
MHC-restricted T ceils, a response that proceeds over a 5-7-d
period (8). Injected dendritic cells that carry the endogenous
Mls superantigen can tolerize developing thymocytes to Mls
antigens over at least 1 wk in situ (47, 48). Third, high levels
of MHC products on dendritic cells would also enable these
APCs to display many different peptides or superantigens,
which may be relevant in responses to complex microbial and
cellular stimuli. Dendritic cells are found in relatively large
numbers in synovial effusions (49). If superantigens are important in rheumatoid arthritis as suggested (50, 51), the ability
of dendritic cells to carry small amounts of superantigen in
a form that is highly stimulatory for T cells suggests that
they would be important APCs for inducing immune responses to these molecules in vivo.
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levels of MHC class II molecules on dendritic cells (6, 15,
28), assuming the superantigen binding sites are unoccupied.
Because dendritic cells comprise ~0.1% of blood leukocytes
but bind >30 times more superantigen than B cells and ~>200
times more than monocytes, it is necessary to isolate this trace
subset of APCs to appreciate the efficacy with which superantigens can stimulate the growth of primary T cells. Not
only are dendritic cells much more efficient on a per cell basis
than other primary APCs in stimulating T cells to proliferate
to superantigen (Fig. 2 B), they also use fewer MHC class
II molecules. We estimate that 25-30-fold fewer class II molecules are engaged by dendritic cells compared with B ceils
to attain a similar degree of T cell stimulation (Pig. 2 B).
The picomolar concentrations of superantigen that are
required to pulse dendritic ceils are 106-fold less than the
micromolar levels required for conventional soluble antigens
(8, 41). Since superantigens bind directly to MHC class II
products (20-22), while most conventional antigens probably do not bind directly and must first be processed, it is
possible that 1/106 of a conventional antigen load is successfully processed by dendritic cells to form MHC class II-peptide complexes.
High levels of MHC class II, a uniform feature of dendritic cells from many different tissues and species (29), have
implied that high levels of signal one underlie their efficacy
as APCs. However, this proved not to be the case for superantigens at least in vitro. An average of just 2,000 bound
molecules of SEA per dendritic cell induced strong responses
in quiescent T ceils (Fig. 3 A). When one considers that 1
dendritic cell can stimulate 10 or more T cells simultaneously
within cell dusters (42), and that our estimates of bound
superantigen could be high if SEA were shed, metabolized,
or bound in part to non-MHC products, then the number
of MHC-associated SEA molecules that are required to stimulate a primary lymphocyte is remarkably small, possibly <200
molecules per T cell. This is true for both naive and memory
T cell subsets, as defined by CD45RA and CD45RO markers
(Fig. 6). These results are similar to those observed during
presentation of MHC-peptide complexes to two T-T hybridomas (1, 2). Because prior work entailed continuous T cell
lines as responders, and cell lines as APCs as well, the relevance to primary T cell stimulation remained open. Our results
show that the delivery of signal one to T cells depends on
the use of relatively few MHC class II-ligand pairs on dendritic cells.
That a few molecules of ligand on the dendritic cell can
successfully stimulate a T cell suggests a role for so-called
accessory or costimulatory molecules. Blood dendritic cells
express an array of various adhesion and/or costimulator molecules (11, 15). To evaluate their role in triggering T cells
with low doses of superantigen, we used blocking mAbs.
This is feasible because human blood dendritic cells lack functioning Fc receptors, as substantiated by the failure of antiCD3 to exert a mitogenic effect (11) (Fig. 7). Antibodies to
CD3, CD4, and CD28 individually blocked the response
~>80%, suggesting that each molecule makes a major contri-
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